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Abstract
Background: Implementation research has delved into barriers to implementing change and interventions for the
implementation of innovation in practice. There remains a gap, however, that fails to connect implementation
barriers to the most effective implementation strategies and provide a more tailored approach during
implementation. This study aimed to explore barriers for the implementation of professional services in community
pharmacies and to predict the effectiveness of facilitation strategies to overcome implementation barriers using
machine learning techniques.
Methods: Six change facilitators facilitated a 2-year change programme aimed at implementing professional
services across community pharmacies in Australia. A mixed methods approach was used where barriers were
identified by change facilitators during the implementation study. Change facilitators trialled and recorded tailored
facilitation strategies delivered to overcome identified barriers. Barriers were coded according to implementation
factors derived from the Consolidated Framework for Implementation Research and the Theoretical Domains
Framework. Tailored facilitation strategies were coded into 16 facilitation categories. To predict the effectiveness of
these strategies, data mining with random forest was used to provide the highest level of accuracy. A predictive
resolution percentage was established for each implementation strategy in relation to the barriers that were
resolved by that particular strategy.
Results: During the 2-year programme, 1131 barriers and facilitation strategies were recorded by change facilitators.
The most frequently identified barriers were a ‘lack of ability to plan for change’, ‘lack of internal supporters for the
change’, ‘lack of knowledge and experience’, ‘lack of monitoring and feedback’, ‘lack of individual alignment with
the change’, ‘undefined change objectives’, ‘lack of objective feedback’ and ‘lack of time’. The random forest
algorithm used was able to provide 96.9% prediction accuracy. The strategy category with the highest predicted
resolution rate across the most number of implementation barriers was ‘to empower stakeholders to develop
objectives and solve problems’.
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Conclusions: Results from this study have provided a better understanding of implementation barriers in
community pharmacy and how data-driven approaches can be used to predict the effectiveness of facilitation
strategies to overcome implementation barriers. Tailored facilitation strategies such as these can increase the rate of
real-time implementation of innovations in healthcare, leading to an industry that can confidently and efficiently
adapt to continuous change.
Keywords: Change facilitation, Implementation factors, Determinants, Tailored interventions, Facilitation strategies,
Pharmacy practice, Change management, Organisational change, Machine learning, Random forest
Contribution to the literature
This paper contributes to implementation literature through:
 The use of innovative data-driven approaches to provide
predictions of effective tailored facilitation strategies to be
used during implementation of innovations.
 The need to tailor change facilitation strategies according to
contextual implementation barriers, rather than a one size
fits all approach to implementation.
 The identification of ‘real-world’ barriers experienced in
community pharmacy during implementation by an
external, objective third party such as a change facilitator.
 Increased efficiency and effectiveness of tailored facilitation
interventions, as change facilitators can start choosing
strategies with the highest predictive resolution rate in
relation to the implementation barrier they uncover in
practice.
 Raising awareness of, and providing, an approach to
understand and overcome implementation barriers for
future implementation projects throughout healthcare.
Background
Governments and health care practitioners share com-
mon goals to improve patients’ clinical outcomes, quality
of life and the rationale use of medicines [1]. To achieve
such goals, there has been an increasing international
trend towards the implementation of professional
pharmacy services in community pharmacy [2, 3].
Professional pharmacy services vary significantly in their
objectives and complexity. These evidence-based services
can include the provision of drug information, clinical
interventions, screening services, medication manage-
ment services or preventive care services for patients
with chronic conditions, amongst others [4]. In the case
of community pharmacy, similarly to other health care
settings, the implementation of new services is often
challenging, with common gaps between the develop-
ment and evaluation of services and their implementa-
tion in routine practice. To assist in bridging this
implementation gap, previous research in pharmacy has
identified ‘external support/ assistance’ as a critical fac-
tor in the implementation process [5, 6]. Similarly, other
studies have demonstrated that with proper external
support, pharmacists can make important progress
towards achieving their implementation goals [7].
The concept of external support provision to aid im-
plementation has been explored in research and practice
environments through change facilitation. For example,
the Promoting Action on Research Implementation in
Health Services (PARiHS) framework presents successful
implementation research as a function of the relation-
ship between evidence, context, and facilitation [8].
Change facilitation has become a key component in
supporting teams during the implementation of change
in practice [9] and has proven effective across a variety
of healthcare settings [10]. A change facilitator can pro-
vide support to stakeholders to ‘realise what they need
to change and how to make changes to incorporate
evidence into practice’ [11]. In addition to the need for
external support, implementation research recognises
that the process of implementation goes beyond simple
dissemination of information, requiring the use of strat-
egies that are more specific to the practice’s settings
[12]. Previous research in pharmacy has used change
facilitators to deliver such strategies, with the ultimate
objective of addressing implementation barriers and
increase the number of professional services provided
[13, 14]. In this sense, the identification of relevant
implementation factors and understanding how they
prevent or enable implementation have been highlighted
as key in aiding the development and assessment of
tailored interventions to assist in the implementation of
innovations such as professional services [15].
The concept of tailored interventions has been
highlighted in the literature with the realisation that ‘no
single strategy appears to be sufficient to drive successful
implementation’ [16–18]. There is, however, a need for
more innovative methods for assessing and prioritising
implementation barriers and tailoring implementation
strategies to such barriers [19]. This approach is likely to
increase the effectiveness of implementation strategies
[19], such as change facilitation. The challenge is that
the majority of randomised controlled trials involving fa-
cilitation rely on patient or implementation outcomes to
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evaluate the facilitation’s success [20], without further
evaluation of the facilitation process or the impact of
specific facilitation strategies. Moreover, the core com-
ponents of effective change facilitation remain unknown.
Determining the potential effectiveness of facilitation
strategies in specific contexts and settings such as com-
munity pharmacy could add evidence on essential activ-
ities required for implementation during the facilitation
process and ensure the delivery of tailored, evidence-
based strategies in research and practice.
As a way of promoting the implementation of profes-
sional services in community pharmacies, the Pharmaceut-
ical Society of Australia (PSA) launched a pharmacy change
commercial programme named ‘Health Destination Phar-
macy’ (HDP) which was delivered from 2016 to 2018. The
primary objective of the programme was to reposition the
pharmacist as a healthcare provider and the pharmacy as a
healthcare destination [15]. To achieve this objective,
change facilitation was used as a key implementation strat-
egy in which participating pharmacies received tailored in-
terventions to facilitate the implementation of professional
services. This study aimed to explore implementation
barriers identified by change facilitators during this 2-year
implementation programme and to predict the effectiveness
of facilitation strategies to overcome implementation bar-
riers using machine learning techniques.
Methods
Study design and context
This study used a mixed-method approach, which
included a qualitative analysis of the barriers and facilita-
tion strategies used by change facilitators during HDP.
The study also included a quantitative analysis of the
effectiveness (based on predictive resolution percentage)
of the facilitation strategies used.
The study was undertaken in community pharmacies
across Australia. During the 2-year change programme,
change facilitators supported pharmacy teams who
signed up for the programme, with the goal of increasing
their provision of professional services. The support of
change facilitators included (1) individual on-site facilitation
visits to the pharmacy every 3 months, (2) identification of
implementation barriers preventing the pharmacist and the
pharmacy team from successfully increasing their provision
of professional services, (3) the provision of tailored change
facilitation strategies to overcome the identified implemen-
tation barriers, and (4) continuous telephone follow-up and
monitoring.
Change facilitator experience and training
All change facilitators were registered pharmacists with
experience in community pharmacy, to ensure their
relatability to the pharmacists and teams whom they
were supporting during implementation. Change facilitators
had varying levels of facilitation and/or coaching expertise,
but all attended a 2-day mandatory training prior to their
allocation into the pharmacies. The 2-day training included
the following:
 Previous pharmacy implementation research [21].
 The use of the Generic Implementation Framework
(GIF) [1] to underpin the implementation process.
 Implementation barriers previously identified in the
literature and existing frameworks such as the
Consolidated Framework for Implementation
Research (CFIR) [22], the Theoretical Domains
Framework (TDF), [19] and the Integrated Checklist
of Determinants of practice (TICD) [23].
 One-on-one coaching strategies using the GROW
model [24] and role-playing of the use of such
models in practice.
 Group facilitation skills training including strategies
to engage teams, brainstorming strategies, conflict
management strategies, and communication
strategies.
 The use of a participant observation guide and data
collection form.
Data collection
Data collection was undertaken on-site in each partici-
pant pharmacy. A participant observation guide was
designed based on previous research [1, 25] and was
used by all facilitators. This guide was developed to allow
facilitators to systematically identify and individually
evaluate each pharmacy, identifying the implementation
factors operating as barriers. During their facilitation
visits, change facilitators used the participant observation
guide and interviewed each participant pharmacist in
order to gain a deep understanding of relevant implemen-
tation factors. Post-visit, change facilitators were required
to transfer the following information to the data collection
form:
a) The identified implementation factors that acted as
barriers. The data collection form included a pre-
defined list of implementation barriers. Change
facilitators could choose the identified barrier from
a drop-down list, or they could add a barrier if they
could not find an appropriate one from the list. The
data collection form also included a section to
provide additional qualitative data regarding the
identified barrier.
b) The facilitation strategies they used to overcome
the identified barriers. Change facilitators
documented the facilitation strategies provided
using qualitative data.
c) At which visit they identified each barrier and
conducted the facilitation strategy.
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d) Whether the barrier was resolved or unresolved.
Change facilitators indicated whether the barrier
was resolved based on the following criteria: (1) if
an agreed upon action by the facilitator and the
pharmacy team member was completed by the next
pharmacy visit or follow-up phone call or (2) if an
increase in the provision of professional pharmacy
services was a direct result from this strategy.
Data coding
To ensure data validity, the research project manager
reviewed the database following each facilitation visit
throughout the 2-year duration of the programme. On
completion of the project, the same researcher coded
the implementation barriers and the facilitation
strategies. Implementation barriers were coded using a
pre-defined list based on the CFIR [22], TICD [23] and
TDF [22] (Additional file 1). Facilitation strategies were
mapped according to those identified from two system-
atic reviews [9, 26] (Additional file 2). One systematic
review looked at facilitation strategies conducted in
nursing, from which the Taxonomy of Facilitation
Strategies was developed [9], and the second systematic
review identified facilitation strategies recorded in ran-
domized controlled trials focusing on the implementa-
tion of innovation in healthcare [26].
Data analysis using the data mining approach random
forest
In pursuit of accurate representation of the data
collected, a descriptive analysis was initially undertaken
to provide a resolution percentage for each of the facili-
tation strategies recorded. However, if one strategy was
only used once and was recorded as having resolved the
barrier, this would give it a 100% resolution rate. If an-
other strategy was used in 10 barriers and was recorded
as having resolved 9 of the 10 barriers, this would have a
resolution rate of 90%. Traditional statistical approaches
were therefore deemed inaccurate in adequate represen-
tation of the effectiveness of the strategies as it is based
purely on the number of times that the strategy was
used. For this reason, machine learning with random
forest (RF) was used as an alternative predictive ap-
proach (Additional file 3). As opposed to the resolution
rate from the statistical analysis approach, when using
RF, a predictive resolution percentage (PRP) is given to
each of the facilitation strategies in relation to the bar-
riers that were resolved by that particular strategy. An
algorithm is used to rank the facilitation of strategies in
order of PRP’s. The higher the PRP, the more likely that
the strategy is predicted to overcome the related barrier.
It should be noted that prediction methods are not as-
sumptions, but are calculated based on the extrapolation
of actual data collected by the change facilitators.
Random forest was used as a supervised classification
method for predicting effective strategies for all barriers.
Supervised classification uses data recorded by the
change facilitators, to train a machine learning model to
predict future outcomes. All strategies in the dataset
were labelled with an outcome: ‘strategy works’ (i.e. the
barrier was resolved) or ‘strategy does not work’ (i.e. the
barrier was unresolved). RF classification algorithm was
chosen, due to its popularity in the industry, explainabil-
ity and accuracy, and its enhanced resistance to overfit-
ting than the standard decision tree models (i.e. not
generalising well to new instances). For example, Khalilia
et al. [27] used RF to predict disease risk of individuals
by analysing their medical diagnosis, RF has also been
used to predict novel risk genes such as lupus nephritis
[28] and has been proposed to predict risk of type II dia-
betes [29]. RF combines great numbers of decision trees
trained randomly and equally from a given dataset. To
ensure the machine learning algorithm used increased
the PRP accuracy, 10-fold cross-validation [26] tech-
nique was adopted, where data was randomly split into
ten groups (folds). For each group, this given group was
taken as a test dataset and the remaining nine groups as
a training set. Then, a model was fitted on a training
dataset and was evaluated on the test set. The evaluation
score was kept and the model was discarded. This pro-
cedure was then repeated ten times. To get a perform-
ance of a model, the average of all ten evaluation scores
was taken.
Reporting of the most common implementation barriers
and strategies
In order to help prioritise the focus on the most
common barriers and the facilitation strategies used to
overcome them, Pareto’s principle was used. Pareto’s
principle states that, for many events, roughly 80% of the
effects come from 20% of the causes. This principle has
been proven effective in organisational decision making
[30]. For this reason, the results reported in this paper
focus on the top 20% of barriers, according to the
frequency in which they appeared in the database.
Results
Nineteen pharmacies participated in the change
programme. They were located across Australia and
ranged in the number of prescriptions dispensed per
year from a minimum of 23,954 to a maximum of
223,269 with an average of 93,239 prescriptions
dispensed per year. The number of employees in the
participant pharmacies ranged from a minimum of
two to a maximum of 46 staff members. Six change
facilitators were allocated to the 19 pharmacies based
on the geographical location of the change facilitator
in accordance to the pharmacy.
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One thousand one hundred thirty-one data points (i.e.
total number of barriers identified and associated facili-
tation strategies provided in the participant pharmacies
during the 2-year programme) were recorded. The
random forest algorithm used was able to provide 96.9%
accuracy in predicting the most effective strategies to
overcome specific barriers to implementation. Table 1
showcases the strategies used to address the top 20%
(n=7) most common implementation barriers identified
by change facilitators across the 2-year programme.
The top 20% most common implementation barriers
‘An inability to plan for change’ was the most commonly
identified barrier. It was identified 184 times across 16
of the 19 pharmacies. This implementation factor is de-
scribed by the TICD checklist as ‘the extent to which
the targeted healthcare professionals are able to plan
necessary changes in order to adhere’. To overcome this
barrier, the change facilitators used strategies to (1)
engage stakeholders by creating ownership of the
change, which had a predictive resolution percentage
(PRP) of 84.23%; (2) equip stakeholders with training
(PRP=83.30%); (3) adapt area of focus to meet change
needs (PRP=81.17%); and (4) empower stakeholders to
develop objectives and solve problems (PRP=80.64%).
‘A lack of internal supporters to change’ also known as
internal change resistance was identified as a barrier 128
times across 18 of the 19 pharmacies. The TICD check-
list describes this barrier as a lack of ‘support provided
by the staff members for the implementation of the
change’. To overcome this barrier, the change facilitators
used strategies to (1) engage stakeholders by creating
ownership of the change (PRP= 78.29%), (2) empower
stakeholders to develop objectives and solve problems
Table 1 Facilitation categories used to overcome common implementation barriers in community pharmacy
Most common barriers to implementing
professional services in community
pharmacy^
Strategy categories* used by change
facilitators to overcome implementation
barriers
The predictive resolution percentage
of the strategy category resolving
the barrier (PRP)a
An inability to plan for change (n=184) Engage stakeholders by creating ownership of the
change
84%
Equip stakeholders with training 83%
Adapt area of focus to meet change needs 81%
A lack of internal supporters of the
change (n=128)
Engage stakeholders by creating ownership of the
change
78%
Empower stakeholders to develop objectives and
solve problems
73%
Create buy-in of the change amongst stakeholders 58%
A lack of knowledge and experience
related to the change (n=84)
Create a collaborative environment conducive of
change
99%
Equip stakeholders with training 93%
A lack of monitoring and feedback of
the change (n=61)
Feedback implementation progress 99%
Ensure continuous monitoring of implementation
measures
68%
A lack of individual alignment with the
change (n=49)
Encourage participation and facilitate discussions
amongst stakeholders
99%
Empower stakeholders to develop objectives and
solve problems
83%
Create buy-in of the change amongst stakeholders 83%
Undefined change objectives and lack of
objective feedback (n=46)
Engage stakeholders by creating ownership of the
change
82%
Empower stakeholders to develop objectives and
solve problems
81%
Communicate the change to stakeholders 63%
A lack of time (n=43) Adapt area of focus to meet change needs 79%
Empower stakeholders to develop objectives and
solve problems
62%
^A total of 1131 barriers were identified across the 19 pharmacies throughout the 2-year period
*The strategy categories were adapted from the taxonomy of facilitation strategies by Dogherty et al.
111 facilitation strategies were coded into 16 facilitation categories; the strategies within each of the above-mentioned categories can be found in Table 2
aPredictive resolution percentage is based on a data-driven approach named decision forest which used data collected by change facilitators indicating whether
each strategy resolved the barrier or not
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(PRP=73.44%) and (3) create buy-in of the change
amongst stakeholders (PRP=57.90%).
‘A lack of knowledge and experience’ was identified as a
barrier 84 times across 18 of the 19 pharmacies. The
TDF describes this implementation factor as ‘the extent
to which the targeted individuals have skills, knowledge
and experience that they need to adhere’. When this
implementation factor became a barrier, i.e. a lack of
knowledge and experience, the change facilitators used
strategies to (1) create a collaborative environment
conducive to change (PRP= 99.80%) and (2) equip
stakeholders with training (PRP=93.44%).
‘A lack of monitoring and feedback’ was identified as a
barrier 61 times across 14 of the 19 pharmacies. The
TICD checklist explains this as ‘the extent to which
monitoring and feedback are needed at an organisational
level and available to sustain necessary changes’. When a
lack of monitoring and feedback was identified by the
change facilitators as a barrier, they used strategies to (1)
feedback progress of implementation measures (PRP=
99.12%) and (2) ensure continuous monitoring of imple-
mentation measures (PRP= 68.09%).
‘A lack of individual alignment with the change’ was
identified as a barrier 49 times across 14 out of the 19
pharmacies. The CFIR defines this as ‘the degree of tan-
gible fit between meaning and values attached to the
change by involved individuals’ own norms, values, per-
ceived risks and needs.’ When there was a lack of indi-
vidual alignment with the change, the change facilitators
used strategies to (1) ensure stakeholders contribute to
the change (PRP=98.79%), (2) empower stakeholders to
develop objectives and solve problems (PRP= 83.13%),
(3) create a case for change (PRP=82.86%) and (4) en-
gage stakeholders by creating ownership of the change
(PRP= 49.38%)
‘Undefined change objectives and lack of objective feed-
back’ was identified as a barrier 46 times across 16 of
the 19 pharmacies. The TICD checklist explains this as
‘the degree to which implementation objectives have
been defined, communicated and achieved by the mem-
bers of the team’. To overcome this barrier, change facil-
itators used strategies to (1) ‘engage stakeholders by
creating ownership of the change’ (PRP= 82.33%), (2)
‘empower stakeholders to develop objectives and solve
problems’ (PRP= 80.55%) and (3) ‘communicate the
change to stakeholders’ (PRP=62.83%)
‘A lack of time’ was identified as a barrier 43 times
across 15 out of the 19 pharmacies. To overcome this
barrier, change facilitators used strategies to ( 1) ‘adapt
area of focus to change requirements’ (PRP=79.09%) and
(2) ‘empower stakeholders to develop objectives and
solve problems’ (PRP=62.25%).
Whilst Table 1 showcases the most common barriers
(n=7) identified and the facilitation categories (n=10)
used to overcome these barriers, Table 2 breaks down
the most effective categories (n=10) to showcase the spe-
cific strategies within each of the categories and the bar-
riers which these categories overcame. The facilitation
category that was used to resolve the most barriers was
‘to empower stakeholders to develop objectives and solve
problems’. This category was used to overcome six bar-
riers including ‘an inability to plan for change’, a ‘lack of
internal supporters for the change’, a ‘lack of individual
alignment to the change’, ‘undefined change objectives’,
a ‘lack of objective feedback’, and a ‘lack of time’. The fa-
cilitation category with the lowest PRP was ‘communi-
cate the change to stakeholders’. This category was used
to overcome the implementation barrier of ‘undefined
change objectives’ and ‘lack of objective feedback’ with a
PRP of 62.83%.
Discussion
This study has shown change facilitation, not only as an
intervention to aid in the implementation of innovation
in practice, but also as a way to unearth implementation
barriers and provide more tailored facilitation strategies
to overcome such barriers within a specific industry such
as community pharmacy.
When surveyed or questioned regarding barriers to
implementation, healthcare professionals may not pro-
vide an accurate representation of the true barriers in
practice, but a perception or assumption of the barrier
[31]. Implementation research has also stressed the need
to focus on what people do rather than what they believe
or intend [32]. Having an external, objective third party,
such as a change facilitator, provides an alternative view
of the barriers with the aim of ‘identifying areas of im-
provement' [33]. An example of this is that the challenge
often posed by pharmacy teams when asked to imple-
ment innovations such as professional services is a ‘lack
of time’ [31, 34, 35]. Whilst a ‘lack of time’ was raised as
a barrier 43 times across the 19 pharmacies over the 2-
year programme, however, in this study, this was not the
most common barrier as recorded by change facilitators.
As identified in this study, the most frequently occur-
ring barrier was the ‘inability to plan for change’, appear-
ing in 16 out of the 19 pharmacies. The consistency of
this barrier in pharmacies across Australia alludes to an
overarching inability for pharmacists to adapt to change.
Such a challenge has previously been highlighted with
an emphasis for pharmacy education to address this bar-
rier to implementation and build pharmacy students’
ability to adapt to change [36]. The ability to plan for
change allows pharmacy teams to become more adapt-
able, which is a major factor in ensuring the sustainabil-
ity of innovation such as professional services in
community pharmacy [37]. For pharmacists in practice,
this can be addressed by governing pharmacy bodies and
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Table 2 Facilitation strategies used by change facilitators to overcome common implementation barriers in community pharmacy
Strategy category to overcome
barrier*
Facilitation strategies within category Most common barriers overcome using
this strategy category (PRP)a
Empower stakeholders to develop
objectives and solve •lems
• Stimulate critical inquiry/ critical reflection
• Utilise think-aloud process
• Utilise brainstorming techniques
• Outlining opportunities presented by change
• Conduct a needs analysis
• Conduct a Strength, Weaknesses, Opportunities and Threats
(SWOT) analysis
• Use prioritisation techniques
• Introduce goal-setting (SMART goals)
• Use consensus-building/shared decision-making
• Providing solutions/advice
• Create/ recommend the creation of a monthly or annual
plan
• Ensure win/win goals (mutually beneficial solutions)
• Use an action planner tool
• Use a mind-mapping tool
• Discuss/ outline best practices
• An inability to plan for change (80.64%)
• A lack of internal supporters of the
change (73.44%)
• A lack of individual alignment with the
change (83.13%)
• Undefined change objectives and lack of
objective feedback (80.55%)
• A lack of time (62.25%)
Engage stakeholders by creating
ownership of the change
• Establish/ allocate roles
• Delegate responsibilities
• Allocate primary champion and/or supporting champions
• Define key performance indicators
• Ask for commitment to the agreed changes
• Encourage collaboration and teamwork
• Recommend or aid in conducting a performance review
• Allocate roles based on skills/ interests
• Emphasise the importance of delegating
• An inability to plan for change (84.23%)
• A lack of internal supporters of the
change (78.29%)
• A lack of individual alignment with the
change (49.38%)
Equip stakeholders with training • Provide/recommend skills/technical training
• Provide knowledge training
• Conduct/ recommend role-playing/role modelling
• Bringing subject matter expert
• Refer to external formal education/training
• Using case studies
• Use a staff scoping and training tool
• Encourage discussion of training topic as a group
• Create/adapt training plan
• Determine training gaps
• Encourage self-learning (e.g reading of journals)
• A lack of knowledge and experience
related to the change (93.44%)
• An inability to plan for change (83.30%)
Adapt area of focus to meet change
needs
• Adapt task allocations by creating a roster to align with
change
• Improve workflow by adapting layout to cater for change
• Adapt vision/mission to align for change
• Review roles to align with change requirements
• Create time-tabling (annual, monthly or weekly time tables)
• Adapt business strategy plan to the change
• Adapt image of organisation towards new changes
• Create/adapt communication plan to new changes
• Adapt process/procedures to new changes
• Encourage regular communication amongst participants to
ensure everyone is aligned to new changes
• An inability to plan for change (81.17%)
• A lack of time (79.09%)
Create buy-in amongst stakeholders • Ask about individual concerns regarding the change
• Address specific individual concerns related to the change
• Motivate group/individuals using stories
• Compare audit results to network benchmarking results
• Emphasise enhanced customer outcomes as opposed to
poor practice
• Outline negative impacts to lack of implementation (using
evidence/opinion)
• Outlining benefits of implementation (using evidence/
opinion)
• A lack of individual alignment with the
change (82.86%)
• A lack of internal supporters of the
change (57.90%)
Create a collaborative environment
conducive to change
• Organise or conduct meetings (face-to-face)
• Lead virtual meeting (coach present digitally e.g. webinar or
skype)
• A lack of knowledge and experience
related to the change (99.80%)
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by pharmacy owners equipping their teams with the
right capabilities to plan for change and become more
adaptable, this is crucial because if ‘pharmacy practice is
to survive as an active participant in emerging healthcare
systems, pharmacy practice must change along with the
rest of health care’ [38].
It is important to note that the change facilitation
categories, with the highest PRP, used to overcome the
‘inability to plan for change’, included helping teams
‘engage stakeholders by creating ownership of the
change’, ‘equipping stakeholders with training’, helping
teams ‘adapt area of focus to meet change needs’, and
‘empowering stakeholders to develop objectives and
solve problems’. Strategies in these categories included
‘stimulating critical inquiry’, ‘utilising brainstorming
techniques’, ‘utilising goal-setting’, ‘using consensus-
building’, ‘shared decision making’ and ‘ensuring mutu-
ally beneficial solutions’. In addition, when looking at
the facilitation category that resolved the most barriers,
this was ‘to empower stakeholders to develop objectives
and solve problems’—another category aimed at empow-
ering teams to solve their own challenges and build their
own plan for change.
A growing body of evidence highlights that perform-
ance can be enhanced when actions are taken that result
in empowering individuals [39, 40]. Empowering em-
ployees can encourage risk-taking, innovation and initia-
tive [41]. High levels of empowerment are also more
likely to promote individual team members’ motivational
states even when there are minor relationship conflicts
within the team [42]. Such knowledge can be used to
educate pharmacy students, pharmacists and pharmacy
owners to empower their teams during the implementa-
tion of innovations such as professional services.
It is also worthwhile noting that the strategy category
with the lowest PRP was ‘to communicate the change to
stakeholders’. This is an interesting finding that conflicts
with much of the literature around the importance of
communication in a team environment [43]. When
looking at the examples within this strategy category
(Table 2), however, all strategies pertain to informing
stakeholders of the changes that are happening, for ex-
ample, inform the entire group of the change and objec-
tives verbally, inform individuals of the change and
objectives verbally, inform using a visual display such as
poster and inform using a written document (email,
letter, etc.). If one looks at the difference between this
category and the categories with the highest PRP’s, these
included ‘engaging stakeholders’, ‘equipping stake-
holders’ and ‘empowering stakeholders’, rather than sim-
ply ‘informing stakeholders’. Challenges with providing
information to others via methods such as email have
been highlighted in previous research, such as ‘the ab-
sence of interpersonal clues’ [44]. In addition, ‘informing
stakeholders’ indicates one-way communication and
therefore may not adequately accommodate for deeper
two-way discussions, active engagement or the ‘oppor-
tunity to interact and develop a shared understanding
about the process they need to undertake to achieve
their shared goals’ [45]. Pharmacy researchers have
Table 2 Facilitation strategies used by change facilitators to overcome common implementation barriers in community pharmacy
(Continued)
Strategy category to overcome
barrier*
Facilitation strategies within category Most common barriers overcome using
this strategy category (PRP)a
Feedback progress of
implementation measures
• Provide constructive feedback
• Acknowledge success/recognise/celebrate achievements
• Provide ongoing encouragement
• A lack of monitoring and feedback
regarding the change (99.12%)
Ensure stakeholders contribute to
the change
• Acknowledge ideas
• Encourage knowledge/experience sharing
• Involve others in the change process
• Acknowledge the importance of individuals’ roles
• A lack of individual alignment with the
change (98.79%)
Ensure continuous monitoring of
implementation measures
• Monitor financial impact
• Measure and monitor customer outcomes
• Monitor service provision
• Monitor Staff measures
• Emphasise ongoing monitoring by stakeholders
• Monitor agreed upon plan/objectives
• Display progress chart
• A lack of monitoring and feedback of the
change (68.09%)
Communicate the change to
stakeholders
• Inform the entire group of the change and objectives
verbally
• Inform individuals of the change and objectives verbally
• Inform using a visual display such as poster
• Inform using a written document (email, letter, etc).
• Undefined change objectives and lack of
objective feedback (62.83%)
*The strategy categories were adapted from the taxonomy of facilitation strategies (Dogherty et al.)
a PRP is the predictive resolution percentage is based on random forest which uses data collected by change facilitators indicating whether the extent which the
strategy is predicted to resolve the barrier
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indicated the need for ‘improved engagement strategies
to increase awareness and acceptance of innovations,
promoting whole-team involvement within pharmacies
to overcome time constraints’ [46].
When reporting on strategies used by change facilita-
tors, it is important to recognise that change facilitators
used a combination of strategies and that, even though
some strategies were more effective than others, they
were still used in combination with others. For example,
to overcome ‘the inability to plan for change’, the most
effective strategy predicted to resolve the barrier was to
‘engage stakeholders by creating ownership of the
change’ which had a PRP of 84%; this, however, was
closely followed with the strategy ‘equipping with train-
ing’ which had a PRP of 83%, and closely after that was
‘adapt area of focus to meet change needs’ which had a
PRP of 81%. Change facilitators used all of these strat-
egies in combination in order to successfully overcome
the ‘inability to plan for change’. Change facilitators,
therefore, must not isolate a change strategy and expect
it to work by itself, but are encouraged to use a combin-
ation of strategies to tackle implementation barriers.
Future application of this research
The challenge of evaluating facilitation strategies has
previously been highlighted [47], with evaluation
predominantly focusing on implementation or patient
outcomes [20]. There is minimal focus on the granular
strategies used by change facilitators during the
implementation of innovation and the link between
barriers and strategies [48]. In this study, change
facilitators were given a tool in the form of an MS Excel
Spreadsheet that enabled them to record implementa-
tion barriers discovered, facilitation strategies conducted
and evaluation of the outcomes of their strategies. Such
an approach can help change facilitators navigate imple-
mentation more systematically and collect effectiveness
data that can be used during subsequent implementation
studies to reduce implementation timeframes and in-
crease adoption by stakeholders.
The data-driven, tailored facilitation approach used dur-
ing this study can be applied to understanding common
barriers to implementing innovation and the most effect-
ive change facilitation strategies to overcome these bar-
riers in other industries outside of pharmacy.
Researchers in pharmacy practice need to further
validate this tailored approach to ensure that implemen-
tation barriers uncovered during this study are consist-
ent across community pharmacy and the effectiveness of
the facilitation strategies is also consistent when imple-
menting different innovations in community pharmacy.
Findings from this research can provide change
facilitators, researchers and implementation teams with
tailored strategies to overcome real-time barriers during
the implementation of innovations in community phar-
macy and other healthcare industries.
Limitations
For increased predictive accuracy, data mining tech-
niques require larger data points. The decision tree ap-
proach was determined as providing the best accuracy
given the limited number of data points collected by the
end of the 2-year programme. As only 19 pharmacies
were involved in the change programme, the degree of
implementation of services in the participating pharma-
cies is not necessarily a true representation of the phar-
macy industry. One can argue that such teams showed a
distinct level of innovation and early adoption that may
not be a true reflection of the pharmacy industry. The
use of a pre-determined and pre-defined list of imple-
mentation barriers aided in minimising coding inaccur-
acies. In addition, the collection of such information
from 6 different change facilitators ensured that there
were multiple independent coders of the implementation
barriers. In terms of the facilitation strategies, however,
limitations also apply to how the collected data was
interpreted and coded by the research project manager,
which is an inherent limitation to qualitative research.
Limitations include research quality that is heavily
dependent on the individual skills of the researcher and
more easily influenced by the researcher’s (and change
facilitators’) personal biases and idiosyncrasies [49].
Conclusion
Results from the current study have provided a better un-
derstanding of implementation barriers in community
pharmacy with the predominant barriers identified during
this study, being an inability to plan for change, lack of in-
ternal supporters of the change and a lack of knowledge
and experience regarding the change. The predicted ef-
fective strategies include those that aim to empower phar-
macy teams to develop objectives and solve problems,
engage teams by creating ownership, and equip teams
with training, whilst the strategies with the lowest predict-
ive resolution percentage are those relating to informing
stakeholders of the changes. This insight not only shapes
the way change facilitators can more effectively implement
tailored facilitation strategies, it can also be used during fu-
ture implementation projects for more efficient real-time
implementation of innovation.
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